The Effects of Vaccines on the Sequelae Rates of Recurrent Infections and the Severity of Pulmonary COVID-19 Infection by Imaging
dc.contributor.author | Bahadir, Suzan | |
dc.contributor.author | Kabacaoglu, Ebru | |
dc.contributor.author | Memis, Kemal Bugra | |
dc.contributor.author | Hasan, Hasan Ilksen | |
dc.contributor.author | Aydin, Sonay | |
dc.contributor.pubmedID | 37631888 | en_US |
dc.date.accessioned | 2024-09-11T12:42:20Z | |
dc.date.available | 2024-09-11T12:42:20Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Although vaccines have been shown to reduce the number of COVID-19 infection cases significantly, vaccine-related reactions, long COVID-19 syndrome, and COVID-19 infection following vaccination continue to be a burden on healthcare services and warrant further scientific research. The purpose of this study was to research the severity of pulmonary COVID-19 infection following vaccination and the sequelae rates of recurrent infections in vaccinated cases by imaging. Patients who underwent follow-up CTs at 1 month, 3 months, and 6 months in our hospital with a diagnosis of COVID-19 were scanned retrospectively. Furthermore, all essential information was gathered from patients' immunization records. The major findings of our study were: (1) sequelae were frequently observed in unvaccinated cases; (2) the correlation between vaccination status and the severity of sequelae was significant; (3) there was not any significant relationship between the vaccine type and the severity of sequelae; and (4) hematocrit, hemoglobin, and lymphocyte parameters may be used as predictors of sequelae rates. COVID-19 infection, although reduced in prevalence following the development of vaccines, still remains a public health concern because of reinfection. Vaccination not only appears to protect against primary infection, but also seems to reduce reinfection and sequalae rates following reinfection. | en_US |
dc.identifier.eissn | 2076-393X | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.scopus | 2-s2.0-85168994585 | en_US |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458389/pdf/vaccines-11-01321.pdf | |
dc.identifier.uri | http://hdl.handle.net/11727/12200 | |
dc.identifier.volume | 11 | en_US |
dc.identifier.wos | 001056821200001 | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.3390/vaccines11081321 | en_US |
dc.relation.journal | VACCINES | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | coronavirus disease | en_US |
dc.subject | thorax CT | en_US |
dc.subject | vaccination | en_US |
dc.subject | reinfection | en_US |
dc.subject | lung complications | en_US |
dc.subject | sequelae | en_US |
dc.title | The Effects of Vaccines on the Sequelae Rates of Recurrent Infections and the Severity of Pulmonary COVID-19 Infection by Imaging | en_US |
dc.type | article | en_US |